Literature DB >> 21163100

[Situations and trends of HIV and syphilis infections among drug users in China, 1995 - 2009].

Wei Guo1, Shu-quan Qu, Zheng-wei Ding, Rui-xue Yan, Dong-min Li, Lan Wang, Lu Wang.   

Abstract

OBJECTIVE: To understand the characteristics and trends of HIV and syphilis infections among drug users.
METHODS: Information was collected regarding HIV and syphilis epidemics, as well as on high risk behaviors from the HIV/AIDS surveillance system. Source of information was from HIV/AIDS case-reporting, sentinel surveillance and trend estimation, related to the changes of distribution among HIV positive drug users prevalence rates on HIV and syphilis together with their high risk behaviors.
RESULTS: Scale number on drug users remained stable in the past six year (from 2003 - 2009), while the proportion of drug users decreased from 44.2% in 2005 to 25.8% in 2009. Based on the information from HIV/AIDS case reporting system, HIV sentinel surveillance data showed that the HIV prevalence of drug users was quite different from those of Southwestern to Northeastern parts of China. The HIV prevalence in Southwestern China was much higher than that of the Northeastern areas. Sentinel surveillance data showed that the average positive rates were 6.2% and 3.7% on HIV and syphilis, among the drug users. As for injecting drug users (IDU), the average rates on HIV antibody syphilis and HCV were 9.2% and 4.0% respectively. Series surveillance data indicated that the HIV epidemic expanded quickly among drug users from 1995 - 1999 but became plateaued after 2000 among the IDUs. HIV antibody positive rate remained at 9.0% - 10.0% in the past three years while syphilis fluctuated between 3.5% - 4.5% in the past three years.
CONCLUSION: Drug users and IDUs still remained an important driven factor for HIV/AIDS epidemic in China, suggesting more specific strategies and methods should be developed, based on the characteristics and trends of HIV epidemic, to optimize the allocation HIV prevention and control resources.

Entities:  

Mesh:

Year:  2010        PMID: 21163100

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  7 in total

1.  Describing the Chinese HIV surveillance system and the influences of political structures and social stigma.

Authors:  Lei Zhang; Eric Pui Fung Chow; Jun Zhang; Jun Jing; David P Wilson
Journal:  Open AIDS J       Date:  2012-09-07

2.  Ability to access community-based needle-syringe programs and injecting behaviors among drug users: a cross-sectional study in Hunan Province, China.

Authors:  Lei Zhang; Xi Chen; Jun Zheng; Junshi Zhao; Jun Jing; Jun Zhang; Eric P F Chow; David P Wilson
Journal:  Harm Reduct J       Date:  2013-05-07

Review 3.  HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis.

Authors:  Xun Zhuang; Yanxian Liang; Eric P F Chow; Yafei Wang; David P Wilson; Lei Zhang
Journal:  BMC Infect Dis       Date:  2012-06-08       Impact factor: 3.090

4.  Barriers and Potential Improvements for Needle and Syringe Exchange Programs (NSPs) in China: A Qualitative Study from Perspectives of Both Health and Public Security Sectors.

Authors:  Fung Kuen Koo; Xi Chen; Eric P F Chow; Jun Jing; Jun Zheng; Junshi Zhao; Lei Zhang
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 5.  Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysis.

Authors:  Hua-Min Sun; Xiao-Yan Li; Eric P F Chow; Tong Li; Yun Xian; Yi-Hua Lu; Tian Tian; Xun Zhuang; Lei Zhang
Journal:  BMJ Open       Date:  2015-01-08       Impact factor: 2.692

6.  Epidemic of HIV infection among persons who inject drugs in mainland China: a series, cross-sectional study.

Authors:  Bo Zhang; Xiangyu Yan; Yongjie Li; He Zhu; Zhimin Liu; Zuhong Lu; Zhongwei Jia
Journal:  Harm Reduct J       Date:  2021-06-12

7.  Estimating the size of HIV key affected populations in Chongqing, China, using the network scale-up method.

Authors:  Wei Guo; Shuilian Bao; Wen Lin; Guohui Wu; Wei Zhang; Wolfgang Hladik; Abu Abdul-Quader; Marc Bulterys; Serena Fuller; Lu Wang
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.